# NEUMORA THERAPEUTICS INC. (NMRA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NMRA/

- Reporting holders: 3
- Reported value: $15.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Legacy Private Trust Co.](https://holderbook.com/funds/1352547-legacy-private-trust-co/) | $14.9K | 25,000 | 0.0% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $472 | 792 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $298 | 499 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $15.7K |
| Q2 2026 | 115 | $147.9M |
| Q1 2026 | 112 | $141.8M |
| Q4 2025 | 102 | $114.2M |
| Q3 2025 | 96 | $93.1M |
| Q2 2025 | 99 | $41.3M |
| Q1 2025 | 116 | $65.7M |
| Q4 2024 | 149 | $978.6M |
| Q3 2024 | 108 | $931.9M |
| Q2 2024 | 93 | $715.4M |
| Q1 2024 | 86 | $731.0M |
| Q4 2023 | 61 | $747.0M |